Article Figures & Data
Tables
- Table 1.
Participant characteristics at the time of buprenorphine treatment program initiation: N = 44.
CHARACTERISTIC VALUE Mean age, y 18.5 Sex, n (%) • Female 29 (65.9) • Male 15 (34.1) Using opioids* regularly, n (%) 44 (100.0) • Regular intravenous use 37 (84.1) • Regular inhalation use 42 (95.5) • Regular oral use 10 (22.7) ↵* Oxycodone was used exclusively.
CHARACTERISTIC VALUE Mean (SD) age, y 24 (2.0) Sex, n (%) • Female 21 (65.6) • Male 11 (34.4) Currently taking BT, n (%) 19 (59.4) Completed high school, n (%) 20 (62.5) Cohabitates with a long-term partner, n (%) 22 (68.7) Has ≥ 1 children, n (%) 19 (59.4) Employed full time, n (%) 12 (37.5) Had ≥ 1 ED visit in the past y, n (%) 6 (18.8) Health self-rating as “good” or “OK” in the past 30 d, n (%) 29 (90.6) Mood self-rating as “happy” or “OK” in the past 30 d, n (%) 26 (81.3) Alcohol use in the past 30 d, n (%) 15 (46.9) Alcohol use in the past 30 d: ≥ 2 drinks/d, n (%) 11 (34.4) Daily cannabis use in the past 30 d, n (%) 7 (21.9) Opioid use in the past 30 d, n (%) 3 (9.4) BT—buprenorphine treatment, ED—emergency department.
CHARACTERISTIC CURRENTLY TAKING BT* YES NO Participant count, n (%) 19 (61.3) 12 (38.7) Mean age, y 25 24 Completed high school, n (%) 12 (63.2) 8 (66.7) Employed full time, n (%) 8 (42.1) 4 (33.3) Has ≥ 1 children, n (%) 13 (68.4) 5 (41.7) Has a family doctor, n (%) 13 (68.4) 4 (33.3) Has received formal substance use counseling in the past y,† n (%) 9 (47.4) 1 (8.3) Any alcohol in the past 30 d, n (%) 7 (36.8) 8 (66.7) ≥ 2 drinks/d of alcohol in the past 30 d, n (%) 5 (26.3) 6 (50.0) Daily cannabis use in the past 30 d (≥ 1 joint), n (%) 5 (26.3) 4 (33.3) Any cocaine use in the past 30 d, n (%) 3 (15.8) 3 (25.0) Any recreational opioid use in the past 30 d, n (%) 2 (10.5) 1 (8.3) Mean cumulative treatment, mo 54 35